Axon Enterprise, Inc $AXON Stock: King Luther Capital Management Corp Boosts Position

King Luther Capital Management Corp raised its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 1,731.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 116,539 shares of the biotechnology company’s stock after purchasing an additional 110,177 shares during the period. King Luther Capital Management Corp’s holdings in Axon Enterprise were worth $49,240,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. New Mexico Educational Retirement Board grew its stake in Axon Enterprise by 5,332.1% in the 3rd quarter. New Mexico Educational Retirement Board now owns 213,807 shares of the biotechnology company’s stock valued at $90,338,000 after acquiring an additional 209,871 shares during the last quarter. Maryland State Retirement & Pension System grew its position in shares of Axon Enterprise by 6,258.0% in the third quarter. Maryland State Retirement & Pension System now owns 260,804 shares of the biotechnology company’s stock valued at $110,195,000 after purchasing an additional 256,702 shares during the last quarter. Cabot Wealth Management Inc. grew its position in shares of Axon Enterprise by 11,781.7% in the third quarter. Cabot Wealth Management Inc. now owns 223,139 shares of the biotechnology company’s stock valued at $94,281,000 after purchasing an additional 221,261 shares during the last quarter. Ritholtz Wealth Management grew its position in shares of Axon Enterprise by 10,951.5% in the third quarter. Ritholtz Wealth Management now owns 220,257 shares of the biotechnology company’s stock valued at $93,063,000 after purchasing an additional 218,264 shares during the last quarter. Finally, UNIVEST FINANCIAL Corp purchased a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $12,961,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 9,605 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This represents a 8.95% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider owned 56,264 shares in the company, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is owned by company insiders.

Axon Enterprise Stock Up 4.3%

AXON stock opened at $315.42 on Thursday. The stock has a market capitalization of $25.68 billion, a P/E ratio of 101.10, a PEG ratio of 5.75 and a beta of 1.48. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.60 and a current ratio of 3.00. Axon Enterprise, Inc has a one year low of $291.45 and a one year high of $665.07. The company has a 50 day moving average price of $426.24 and a two-hundred day moving average price of $470.65.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. During the same period in the prior year, the company earned $1.17 EPS. The company’s revenue for the quarter was up 27.8% compared to the same quarter last year. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Recent Axon Enterprise Headlines

These are some of the AXON headlines that stood out recently:

Analysts Set New Price Targets

Several brokerages recently issued reports on AXON. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 price target for the company. in a research report on Friday, November 6th. UBS Group boosted their price target on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 3rd. Finally, Northcoast Research increased their price objective on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $612.18.

Read Our Latest Research Report on Axon Enterprise

Axon Enterprise Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.